Raymond James & Associates’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-13,960
Closed -$51K 3269
2017
Q1
$51K Buy
+13,960
New +$51K ﹤0.01% 3071